Patents by Inventor Christine Massardier

Christine Massardier has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • QUINAZOLINONE DERIVATIVES AND USES THEREOF FOR TREATING A CANCER
    Publication number: 20230150978
    Abstract: The present invention relates to a new class of quinazolinone derivatives of formula (I), and their uses for treating a cancer. The present invention further relates to pharmaceutical compositions comprising compounds of formula (I).
    Type: Application
    Filed: March 29, 2021
    Publication date: May 18, 2023
    Inventors: LAURÈNE MEYNIEL-SCHICKLIN, PETER MACHIN, ERIC MELDRUM, BENOÎT DE CHASSEY, FABRICE GUILLIER, CHRISTINE MASSARDIER, JÉRÔME AMAUDRUT, CHRISTIAN MONTALBETTI, DAVID COUSIN, JEAN-LAURENT PAPARIN
  • INHIBITORS OF THE YAP/TAZ-TEAD INTERACTION AND THEIR USE IN THE TREATMENT OF CANCER
    Publication number: 20210323982
    Abstract: The invention relates to compounds of formula (I): wherein R1, R2, R3, R4, R5 and are as defined in the description.
    Type: Application
    Filed: October 2, 2019
    Publication date: October 21, 2021
    Inventors: Martine BARTH, Sylvie CONTAL, Jean-Louis JUNIEN, Christine MASSARDIER, Christian MONTALBETTI, Anne SOUDE
  • NEW COMPOUNDS INHIBITORS OF THE YAP/TAZ-TEAD INTERACTION AND THEIR USE IN THE TREATMENT OF MALIGNANT MESOTHELIOMA
    Publication number: 20200115353
    Abstract: The invention relates to compounds of formula: wherein R1 to R7 are as defined in the description. These compounds are useful as inhibitors of the YAP/TAZ-TEAD interaction.
    Type: Application
    Filed: April 6, 2018
    Publication date: April 16, 2020
    Inventors: Martine BARTH, Slyvie CONTAL, Jean-Louis JUNIEN, Christine MASSARDIER, Christian MONTALBETTI, Anne SOUDE
  • NEW PHENYLAZETIDINECARBOXYLATE OR -CARBOXAMIDE COMPOUNDS
    Publication number: 20170066717
    Abstract: The invention relates to compounds of formula (I). where R, R1, R2, n, A and Cy have the meanings indicated in the description. The compounds of formula (I) are Nurr-1 modulators.
    Type: Application
    Filed: February 19, 2015
    Publication date: March 9, 2017
    Inventors: Benaissa BOUBIA, Christine MASSARDIER, Fabrice GUILLIER, Olivia POUPARDIN, Mireille TALLANDIER, Jerome AMAUDRUT, Michel BONDOUX, Roelof Williem FEENSTRA, Maria Johana Petronella VAN DONGEN
  • LXR receptor modulators
    Patent number: 7872021
    Abstract: Benzenesulfonamide derivative compounds corresponding to the general formula (I): and their pharmaceutically acceptable addition salts; a process for preparation of such compounds; pharmaceutical compositions containing such compounds, and the use of such compounds as a pharmacologically active substance, in particular in the treatment of neurodegenerative diseases, cardiovascular diseases, inflammatory diseases; hypercholesterolemia, and diabetes.
    Type: Grant
    Filed: November 7, 2006
    Date of Patent: January 18, 2011
    Assignee: Laboratories Fournier S.A.
    Inventors: Luc Lebreton, Christine Massardier, Christine Dumas, Pierre Dodey, Philippe Masson
  • Benzenesulphonamide derivatives, method for production and use thereof for treatment of pain
    Patent number: 7538111
    Abstract: The present invention concerns novel benzenesulphonamide compounds, defined by formula I. Therapeutic compositions comprising the benzenesulphonamide compounds of the invention or salts thereof and methods for producing the benzenesulphonamide compounds of the invention are also disclosed. The benzenesulphonamide compounds of the invention or salts thereof are useful for treating pain, such as hyperalgesia and major algesia.
    Type: Grant
    Filed: March 24, 2004
    Date of Patent: May 26, 2009
    Assignee: Laboratoires Fournier S.A.
    Inventors: Martine Barth, Michel Bondoux, Pierre Dodey, Christine Massardier, Didier Thomas, Jean-Michel Luccarini
  • Indoline compounds
    Patent number: 7465811
    Abstract: Sulfonylindoline compounds of formula I, wherein R1 through R4, Y and Z have defined meanings, a process for preparation of such compounds, and the use as pharmaceutically active substances, particularly for the treatment or inhibition of neurodegeneration, cardiovascular disease, inflammatory disease, hypercholesterolemia, dyslipidemia, obesity or diabetes.
    Type: Grant
    Filed: November 30, 2007
    Date of Patent: December 16, 2008
    Assignee: Laboratoires Fournier S.A.
    Inventors: Luc Lebreton, Christine Dumas, Christine Massardier, Michel Bondoux
  • Novel Indoline Compounds
    Publication number: 20080119465
    Abstract: Sulfonylindoline compounds of formula I, wherein R1 through R4, Y and Z have defined meanings, a process for preparation of such compounds, and the use as pharmaceutically active substances, particularly for the treatment or inhibition of neurodegeneration, cardiovascular disease, inflammatory disease, hypercholesterolemia, dyslipidemia, obesity or diabetes.
    Type: Application
    Filed: November 30, 2007
    Publication date: May 22, 2008
    Applicant: Laboratories Fournier S.A.
    Inventors: Luc LEBRETON, Christine Dumas, Christine Massardier, Michel Bondoux
  • Arylsulphonamide derivatives and methods of preparing
    Patent number: 7361687
    Abstract: The present invention relates to novel arylsulphonamide compounds, defined by formula I and the description, as well as their method of preparation and their therapeutic use
    Type: Grant
    Filed: June 12, 2003
    Date of Patent: April 22, 2008
    Assignee: Laboratoires Fournier SA
    Inventors: Martine Barth, Michel Bondoux, Pierre Dodey, Christine Massardier, Jean-Michel Luccarini
  • LXR receptor modulators
    Publication number: 20070099960
    Abstract: Benzenesulfonamide derivative compounds corresponding to the general formula (I): and their pharmaceutically acceptable addition salts; a process for preparation of such compounds; pharmaceutical compositions containing such compounds, and the use of such compounds as a pharmacologically active substance, in particular in the treatment of neurodegenerative diseases, cardiovascular diseases, inflammatory diseases; hypercholesterolemia, and diabetes.
    Type: Application
    Filed: November 7, 2006
    Publication date: May 3, 2007
    Applicant: Laboratoires Fournier S.A.
    Inventors: Luc Lebreton, Christine Massardier, Christine Dumas, Pierre Dodey, Philippe Masson
  • Benzenesulphonamide derivatives, method for production and use thereof for treatment of pain
    Publication number: 20060178360
    Abstract: The present invention concerns novel benzenesulphonamide compounds, defined by formula I and the description, their method of preparation and their use in therapy.
    Type: Application
    Filed: March 24, 2004
    Publication date: August 10, 2006
    Applicant: Laboratoires Fournier S.A.
    Inventors: Martine Barth, Michel Bondoux, Pierre Dodey, Christine Massardier, Didier Thomas, Jean-Michel Luccarini
  • Novel arylsulphonamide derivatives and use thereof as therapeutic agents
    Publication number: 20060084699
    Abstract: The present invention relates to novel arylsulphonamide compounds, defined by formula I and the description, as well as their method of preparation and their therapeutic use.
    Type: Application
    Filed: June 12, 2003
    Publication date: April 20, 2006
    Inventors: Martine Barth, Michel Bondoux, Pierre Dodey, Christine Massardier, Jean-Michel Luccarini